(Total Views: 213)
Posted On: 10/26/2022 5:47:34 PM
Post# of 4
FDA 501(k) clearance for 30 day use of the EVO sEEG system is huge news, and takes the shackles off of Zimmer Biomet to market this product.
The share price drop, in the face of this great news, is perplexing, but will likely be followed by a sharp rebound once this news is fully processed by the market.
The share price drop, in the face of this great news, is perplexing, but will likely be followed by a sharp rebound once this news is fully processed by the market.
(1)
(0)
The Lawman
style="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]
